Clinical Trial Update: Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a targeted ALK therapy in ALK-positive non-squamous non-small cell lung cancer patients who have been previously treated was terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Not disclosed

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2023-11-21